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I. INTRODUCTION 
Bovine respiratory disease (BRD) remains the number one 
disease problem to the cattle industry in the United States. 
BRD is caused by a complex multiplicity of infectious agents 
including bacteria, mycoplasmas, chlamydia and viruses. 
Stress factors, nutrition, environment and many other factors 
play a role in the incidence of respiratory disease. 
Many years of research have characterized the major 
causes of bovine respiratory disease. Potent vaccines are now 
available for the protection of animals against infectious bo-
vine rhinotracheitis, parainfluenza-3, and bovine viral diar-
rhea. 
An unending string of agents are being identified that. 
' are associated with BRD. Many of these agents, either alone 
or in combination with other agents, are capable of producing 
respiratory disease in cattle. 
The purpose of this study was to characterize an isolant 
from a clinical case of BRD and to ascertain its role in BRD 
alone and with Mycoplasma agalactiae var bovis, a mycoplasma 
which commonly infects cattle. 
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II. LITERATURE REVIEW 
A. History of Rhinoviruses 
Kruse (44) first demonstrated that a common cold could be 
caused by nasal inoculation with a bacteria-free filtrate, in-
dicating a viral etiology. The etiology of the common cold 
.. 
was studied further for many years before the isolation and 
identification of rhinoviruses. Recent work (77), however, 
indicated that most cases of the common cold were due to in-
fection with these organisms. 
In 1953 the DC strain (type 9) became the first rhino-
virus to be propagated in vitro when it was passaged serially 
in explants of human embryonic lung in roller tubes (3) • 
Tyrrell and Parsons (78) demonstrated that the viruses causing 
common cold would produce cytopathic effects in tissue culture 
of human embryonic kidney cells, if they were incubated in 
roller tubes at 33 C in a medium having low pH. The discovery 
of a semicontinuous strain of diploid human embryonic lung 
fibroblasts (26) initiated an explosive increase in the number 
of viruses isolated. 
Many synonyms have been suggested for the viruses of the 
common cold: rhinoviruses (2); coryzaviruses (24); entero-
like viruses (36); muriviruses and respiroviruses (52); .. and 
ERC (echo-rhino-coryza) group (42). Rhinovirus, derived from 
the special adaptation of these viruses to grow in the nose, 
is now the generally accepted name (4). 
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The World Health Organization initiated a Rhinovirus Col-
laborative Program in which all rhinoviruses were compared in 
cross neutralization tests with specific antisera. The first 
phase revealed 55 distinct serotypes and one subtype (38). 
This system was extended to 89 serotypes in 1971 (39). Recent 
isolations have been made in ciliated epithelial cells of hu-
man embryonic nasal epithelium maintained in organ culture. 
Isolants may be adapted to cell cultures after several pas-
sages in organ cultures, while others are unable to replicate 
in anything but ciliated epithelial cells (59,60). Prelimi-
nary data indicate that there are now 110 serotypes of human 
rhinovirus (35). 
Rhinoviruses were isolated from horses by Plummer (61) 
and two distinct serotypes were isolated from cattle by Bogel 
and Bohm (9) and Reed ~t al. (66). 
The International Committee on Nomenclature of Viruses 
(82) additionally included the foot-and-mouth disease virus as 
a rhinovirus. Newman et al. (56) proposed that rhinoviruses, 
foot-and-mouth disease virus and equine rhinovirus be placed 
into separate subgroups of the family Picornaviridae based on 
distinct differences of buoyant density in cesium chloride, 
stability at pH 3 to 7 and the base composition' of the viral 
RNA. Foot-and-mouth disease virus, an acid labile picorna-
virus primarily of cattle was considered a·rhinovirus, with 
the primary criterion being acid lability (62). However, it 
caused a disease quite different from that produced by other 
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rhinoviruses. Equine rhinovirus differed from other rhino-
viruses in that it would multiply in a wide variety of cells 
(11), was not inhibited by (S,S)-1,2 bis(5-methoxy-2-benzi-
mazolyl)-l-2-ethanediol (70) and, rather than being host spe-
cific, had been shown to infect human beings (61) and vervet 
monkeys ( 4 7) . 
Human rhinovirus research has been adequately reviewed 
(1,25,35,73,74,76) and is not detailed herein except when 
relevant to the subject. 
B. Classification of Rhinoviruses 
The name picornaviruses was proposed in 1963 (51) to in-
clude all small (pico) viruses that contain infectious·ribo-
nucleic acid (RNA). The viruses of the family Picornaviridae 
were found to conform to the cryptogram R/l : 1-2.5/30: S/S 
V/O (.82). They were particles 20 to 40 nm in diameter of 
cubic symmetry containing single stranded RNA of molecular 
weight 2.5 X 10 6 daltons and were non-enveloped (naked). 
Viral synthesis and maturation occurred in the cytoplasm with 
the occasional formation of crystalline arrays of particles 
( 82) . 
The family Picornavir~dae was subdivided into genera 
Enterovirus (enterovirus, poliovirus, coxsackievirus and echo-
virus), Rhinovirus (human, equine, bovine and foot-and-mouth 
disease virus), and Calicivirus (vesicular exanthema and fe-
line picornavirus) (82). Based on distinct differences of 
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buoyant density in cesium chloride, stability at pH 3 to 7 and 
the base composition of the viral RNA it was proposed that the 
family Picornaviridae more correctly should be divided into at 
least six subgroups: enteroviruses; rhinoviruses; calicivi-
ruses; cardioviruses; foot-and-mouth disease virus; and equine 
rhinovirus (56). 
Rhinoviruses are the largest genus of the family 
Picornaviridae and conform to the cryptogram R/l : 2.6-2. 
8/30 : S/S : V/O (82) • Members of the genus Rhinovirus are 
particles 20 to 30 nm in diameter with cubic symmetry and are 
non-enveloped (naked) . They have single stranded RNA with a 
molecular weight of 2.6 to 2.8 x 10 6 daltons, which is about 
30 percent of the total particle weight, with a base composi-
tion of G 20-24: A 26-34 : C 20-28 : u 22-26. They are la-
bile at pH 3, ether and chloroform stable and some are sta-
bilized against thermal inactivation by Mgcl 2 • They have a 
buoyant density of 1.38 to 1.43 g/cm3 and a sedimentation co-
efficient of 140 to 150 S. They replicate in the cytoplasm 
of cells of the respiratory tract (82). 
C. Bovine Rhinoviruses 
Bogel and Bohm (9) first isolated a bovine rhinovirus in 
Germany (strain Sd-1). Subsequently, Wizigmann and Schiefer 
(83) isolated strain 181/V in Germany. In England Ide and 
Darbyshire (29) isolated RS 3x and Reed et al. (66) .isolated 
ECll. Mohanty and Lillie (54) first isolated bovine rhino-
, 
/ 
/ 
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virus, strain C-07, in the United States (Maryland) and 
Rosenquist (68) made subsequent isolations in Missouri. 
Most bovine rhinoviruses were serologically related, in 
contrast to the large number of human serotypes. Mohanty and 
Lillie (54) found that C-07 was related but not identical to 
Sd-1 and 181/V. Antiserum prepared against C-07 neutralized 
Sd-1 and 181/V at 8-and 16-fold lower titers, respectively, 
than the homologous strain. Ide and Darbyshire (34) concluded 
that strains Sd-1, 181/V, C-07 and RS 3x were antigenically 
similar. It was found that RS 3x was more closely related to 
Sd-1 strain than to C-07 strain. Betts et al. (5) found that 
serum from a calf infected with ECll strain neutralized strain 
ECll, but not strain Sd-1. It appeared that strains Sd-1, 
181/V, C-07 and RS 3x were all antigenically related, and were 
antigenically distinct from strain ECll (34). 
No serological relationship has been demonstrated between 
the bovine rhinoviruses and human rhinoviruses (8). 
1. Isolation and growth in tissue and organ cultures 
Human rhinoviruses have been grouped according to their 
ability in early passage to produce cytopathic effect only ·on 
human cell cultures (H strains), or on both monkey and human 
cells (M strains) , the latter was comprised of relatively .few 
serotypes (76). Another term, O strains, was used recently 
for viruses which were cultivated in organ cultures of human 
respiratory epithelium. While some strains replicated only in 
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organ cultures, others could be adapted to replicate in human 
embryo fibroblasts, and were then referred to as 0-H strains 
( 76) . 
The bovine rhinoviruses were shown to possess a very nar-
row host range comparable to the human rhinoviruses of the H 
type. Bovine rhinoviruses were found to replicate preferen-
tially in calf kidney cells (8). Bovine rhinovirus isolations 
were made in stationary cultures of bovine kidney celis (9,?4, 
68,83). Ide and Darbyshire (29) utilized rolled ·cultures of 
bovine kidney cells in the isolation of RS 3x. Reed et al. 
(66) isolated strain ECll in calf tracheal organ cultures. 
Only after eight passages in organ culture could the virus be 
adapted to calf kidney cells. 
There is limited information available that indicates 
that the bovine rhinoviruses are tissue specific as wel.l as 
species specific with regard to the cells in which they will 
replicate. Cytopathic effect was reported (30) in primary 
calf testis cultures, which on initial passage was transient. 
Virus replication occurred in primary calf thyroid cells with-
out cytopathology until the third passage, when the cytopathic 
effect became identical to that found in calf kidney cells 
(.30). Using Madin Darby bovine kidney cells (MDBK) a cyto-
pathic effect similar to that found in primary bovine kidney 
cells was observed, but a very low viral titer was obtained 
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(66). MDBK cells were used in plaque assay of strains Sd-1, 
181/V, C-07 and RS 3x (34). 
Bogel (8) determined that a minimum of three passages at 
five day intervals should be made before a sample is consid-
ered negative for bovine rhinoviruses. On initial isolation 
only a few rounded cells were seen in focal areas (68). These 
cells were subsequently released from the monolayer (8). 
After several passages CPE could be detected as early as two 
days (68). 
Bovine rhinoviruses replicated in organ cultures of tra-
chea and turbinate explants with a resultant patchy cell dam-
age characterized by loss of cilia, cellular disorientation. 
and epithelial cell desquamation (30). 
No replication of bovine rhinovirus was detected in bo-
vine testicle (68) or amniotic and lymph node cells (8). 
Cells derived from heterologous species, including porcine 
kidney, guinea pig kidney, mouse kidney, chicken fibroblasts 
(8); HeLa, Vero, hampster kidney (BHK), rat embryo kidney, or 
L cells (30); and, Hep-2, primary human embryo kidney, pri;_ 
mary monkey kidney and diploid semicontinuous human embryo 
lung cells (66), did not exhibit any cytopathic effect or de-
monstrable replication of bovine rhinovirus. Additionally, 
clinical signs were not evidenced in mice inoculated intra-
peritonea:lly, intracerebrally and subcutaneously. Guinea pigs 
showed no clinical signs after ino6ulation, and the virus 
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could not be reisolated after inoculation by several different 
routes in embry6nating chicken eggs (8). Chickens and rabbits 
did not show clinical signs following intravenous inoculations 
( 54) • 
One of the first successful demonstrations of the pres-
ence of rhinoviruses in vitro was by the interference tech-
nique (27). The utilization of the interference of non-cyto-
pathogeni·c rhinoviruses against echovirus type II in human 
embryo kidney cells allowed the isolation and early character-
ization of rhinoviruses which would not cause detectable cyto-
pathic !3ffect until after at least 12 passages in culture 
( 57) • 
Rhinoviruses·were not isolated with ease until the inocu-
lated cultures were rolled during incubation at 33 C and main-
tained in medium containing less than 0.09% sodium bicarbonate 
buffer ( 78). No disadvantage with the stationary incubation 
of bovine rhinoviruses was noted by Bogel (8). However, the 
extent of cytopathic effect was increased further by rolling 
the cultures according to Ide and Darbyshire (30). Cytopathic 
effect appeared earlier in rolled cultures, was more advanced 
at three days after inoculation and, in 50 percent of inocu-
lated cultures was more advanced at six days. Cultures at 
37 C had the least advanced cytopathic effect throughout the 
period of incubation (68). 
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The cytopathic effect produced by bovine rhinoviruses 
appeared more rapidly and was more progressive in cultures in-
cubated at 33 C than in those incubated at 37 C. The virus 
titers obtained at 33 C were higher than when incubated at 37 
C (9,30,54,68,83). The effect was probably due to a more 
rapid thermoinactivation .of the viruses at 37 C (30). Inacti-
vation occurred at the lowest temperature that inactivated the 
least stable component, either coat protein or nucleoprotein. 
MgC1 2 stabilized strain C-07 against thermoinactivation but 
strains Sd-1, 181/V (54) and RS 3x (31) were not stabilized. 
Bogel (8) observed that the maintenance medium for cul-
turing rhinoviruses must have a pH of 6.8 to 7.3. The utili-
zation of a low bicarbonate buffer concentration (less than 
0.09%) had long been recognized as a requirement to produce 
cytopathic effect in human embryonic kidney and monkey kidney 
cell cultures (78). In human diploid and HeLa cell cultures 
the incubation temperature and bicarbonate concentrations were 
less critical (24). The most sensitive cells for primary iso-
lation of rhinoviruses (semicontinuous human lung and kidney 
fibroblasts) had a less critical medium pH requirement (37). 
The final titers with high and low bicarbonate concentrations 
(30) were found to be equal although maximal titers were at-
tained more rapidly and the CPE was more pronounced with low 
bicarbonate concentrations. The CPE with high bicarbonate 
level often was obscured by regrowth of the monolayer. 
11 
cultures at low bicarbonate concentration did not regrow, but 
were more acid and had non-specific cell degeneration (68). 
( 
Under optimal conditions for the replication or rhino-
viruses, cytopathic effect could be observed in a monolayer of 
cells grown on the surface of a tube or flask. Under such 
conditions CPE appeared from .18 hours to two weeks after in-
oculation depending on the concentration and type of rhino-
virus. When high concentrations were used CPE was diffuse but 
in low concentrations small foci appeared, which enlarged 
until they coalesced with other foci. These foci or micro-
plaques were apparently each initiated by a single infectious 
viral particle (58). 
The initial CPE evident in infected cells was an irregu-
larity in outline, a rounded appearance and increased refrac-
tiveness (68). Reed et al. (66) described small foci con-
sisting of six to ten rounded, refractile cells on an intact 
mono layer. The. cells either lyse or detach from the surface 
as the CPE progresses in a slow manner that finally involves 
from 50 to 75 percent of the monolayer (68). Gaps appeared in 
the monolayer until a stage was reached where a lacy appear-
ance was produced by narrow strands and islets of intact cells 
outlined by rounded and distorted cells (66). 
Cellular changes were characterized by a retraction of 
cytoplasmic boundaries, often with an exhibition of intensely 
eosinophilic cytoplasmic masses that displaced the nucleus 
(which became pycnotic) and finally a complete cell shrinkage 
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(30). Infected cells stained with acridine orange exhibited 
flame red cytoplasmic masses that corresponded in location and 
morphology to granular cytoplasmic areas seen in cells stained 
with hematoxylin and eosin (30,31). 
Electron micrographs of cells infected with human rhino-
virus type 2 exhibited the appearance of large clusters of 
ribosomes (polyribosomes) , the development of multiple cyto-
plasmic vesicles containing membrane bound bodies and the for-
mation of dense granular intracytoplasmic material. These 
bodies proliferated until the nucleus was displaced. Progeny 
virions were recognized associated with parallel rows of fi-
brils and were also exhibited as crystals of closely packed 
viral particles (41). 
Bovine rhinovirus RS 3x replicated in both trachea and 
turbinate organ cultures (30). Strain ECll was isolated using 
trachea organ cultures and could not be adapted to bovine kid-
ney cells until after the eighth organ culture passage (66). 
The ciliary activity of infected epithelial cells diminished 
and ultimately ceased (66). Histologically the infected organ 
cultures became non-ciliated and low columnar, cuboidal or 
squamous in appearance (30). The cellular damage was patchy 
and characterized by marked destruction and shedding of cili-
ated cells (65,66) with a disruption of normal cellular orien-
tation (30). Peak titers of virus coincided with the cessa-
tion of ciliary activity (30). 
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Plaque assay for rhinoviruses was first described by 
Parsons and Tyrrell (58) who counted microplaques under a 
fluid overlay. Macroplaques were demonstrated under an agar 
overlay by Porterfield (63). Fiala (16) plagued all of the 
first 55 serotypes of human rhinovirus utilizing 30 mM MgC12 
and 30 µg/ml of DEAE-dextran in an overlay of agarose. Ide 
and Darbyshire (34) plaqued bovine rhinovirus strains RS 3x, 
181/V, C-07 and Sd-1 under 1.2% Noble agar. Rosenquist (68) 
was unable to produce plaques in bovine embryonic kidney cells 
with his isolants. 
The rate of rhinovirus RNA synthesis was increased when a 
PPLO medium was utilized for culturing rhinovirus infected 
cells. The synthesis of rhinovirus RNA has also been found to 
be greater in cell cultures infected with Mycoplasma pneu-
moniae (18,50). Additionally, Reed (64) showed that dual in-
fection of tracheal organ cultures with bovine rhinovirus 
strain Sd-1 and Mycoplasma hyorhinis resulted in ~ hyorhinis 
replicating more rapidly and to a higher titer than in con-
trol cultures. 
2. Physical and chemical properties of bovine rhinoviruses 
Stott and Killington (73) observed that relatively little 
was known about the replication and other properties of bovine 
rhinoviruses. 
Bogel (8) calculated the size of bovine rhinovirus to be 
25 nm according to the sedimentation constant. Mohanty and 
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Lillie (54) determined the size to be 25 to 27 nm according to 
electron micrographs and Ide and Darbyshire (31) estimated a 
size of 24 nm based on filtration. 
The nucleic acid was determined to be ribonucleic acid 
(RNA) by several investigators. Rosenquist (68) determined 
the nucleic acid type in the direct method (23) using 5-bromo-
deoxyuridine (BUDR) and thyrnidine and in the indirect method 
(24) using BUDR alone. The RNA content of bovine rhinoviruses 
was determined additionally by indirect methods using 5-iodo-
desoxyuridine (IUDR) (8,31), 5-bromodeoxyuridine (BUDR) (66) 
and 5-fluorodeoxyuridine (FUDR) (54). 
Bogel (8) determined the sedimentation .constant of bovine 
rhinovirus to be ca. 145 s. Ide and Darbyshire (31) found 
that the buoyant density in cesium chloride was ca. 1.40 
gm/ml. 
The resistance of bovine rhinoviruses to lipid solvents 
indicated that·lipids were not an essential structural element 
(8). Bogel (8) found bovine rhinovirus to be resistant to 
chloroform and sodiurn-dodecyl-sulfate (SDS). Ide and 
Darbyshire (31) observed an increase in titer with chloroform 
treatment. Reed et al. (66) found bovine rhinovirus resistant 
to ether treatment. Sodium desoxycholate did not reduce in-
fectivity (31). Ide and Darbyshire (31) found a marked reduc-
tion of infectivity when bovine rhinovirus was exposed to 
sodiurn-dodecyl-sulfate (SDS) for one hour. Viruses inacti-
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vated by SDS usually, but not always, were those that con-
tained lipids (81). 
Bogel (8) found that strain Sd-1 was trypsin resistant. 
Ide and Darbyshire (31) found strain RS 3x to be trypsin sen-
sitive and suggested that bovine rhinoviruses were variable in 
sensitivity to this enzyme. 
Bogel (8) determined that the acid stability of isolants 
would differentiate between enteroviruses and rhinoviruses. 
Ide and Darbyshire (31) showed that rhinoviruses were stable 
at pH 6. 0 to 8. 0 but rapidly lost infectivi ty outside this 
range. Rosenquist (68) found incubation at 4 C to be neces-
sary to preclude thermal inactivation while determining acid 
!ability. 
Rosenquist (68) found bovine rhinovirus isolants to be 
very heat sensitive. Ide and Darbyshire (31) demonstrated a 
significant difference between inactivation at 33 c and 37 C. 
The titer of rhinovirus at 37 c dropped significantly within 
six hours (8). Ide and Darbyshire (31) reported loss of 
approximately io1 · 0 TCID50 infectivity after 40 days storage 
at 4 C, io 0 • 5 TCID50 at -20 C for one year and no loss of 
titer at -70 C for one year. 
Mohanty and Lillie (54) found that strain C-07 was sta-
bilized a,gainst thermal inactivation at 50 C by molar MgC1 2 , 
whereas strains Sd-1, 181/V (31,54) were not stabilized. 
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3. Serology of bovine rhinoviruses 
Hyperimmune sera against bovine rhinoviruses have been 
produced in guinea pigs, rabbits, calves (34) and chickens 
(54). Mohanty and Lillie (54) reported repeated failures to 
produce hyperimmune sera in guinea pigs and rabbits. 
Rosenquist (68) reported at least an eight-fold increase 
in neutra:t.izing titer in paired sera from three naturally in-
fected animals. Bogel (8) found that active immunity produced 
low to moderate titers (1:2 to 1:32). Infection with bovine 
rhinovirus was shown to occur in the presence of relative high 
serum titers. 
Neutralization tests with calf kidney cells in tubes (8, 
66,68) and plaque reduction test (34) have been utilized for 
serological tests. Bogel (8) concluded that most other tests 
would be difficult to apply to bovine rhinovirus because of 
the relative low yield of virus in tissue culture. 
Ide and Darbyshire (33) found that neutralizing antibody 
to bovine rhinovirus was passively transferred in colostrum. 
The titer initially dropped and then ap average ten-,fold in-
crease occurred as the animal was naturally exposed to the 
virus. 
Serological investigations have indicated that .a high 
proportion of cattle possess neutralizing antibodies to bovine 
rhinovirus. Bogel (8) reported 67 percent incidence, Mohanty 
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and Lillie (54) 95 percent incidence and Ide and Darbyshire 
(33) 92 percent incidence of tested sera positive for rhino-
virus antibodies. 
4. Pathogenesis and pathology of bovine rhinovirus infection 
Bogel (8) found bovine rhinovirus infection to be wide-
spread in cattle but believed that these viruses were rarely 
associated with respiratory syndromes. Mohanty and Lillie 
(54), Ide and Darbyshire (29) and Reed et al. (66) isolated 
bovine rhinoviruses from apparently normal cattle. Rosenquist 
(68) recovered four isolants from cattle that had clinical 
signs of respiratory disease. Significant increases in titer 
to the homologous isolants plus the failure to detect other 
pathogens serologically or by isolation techniques suggested 
rhinoviruses as the causal agent in the infection. 
Several workers have failed to produce symptoms of res-
piratory disease in calves inoculated with bovine rhinovirus 
(9,32,49,83). 
Betts et al. (5) observed clinical signs consisting of a 
diphasic temperature increase of 1 to 2 C with peaks at 36 to 
48 hours and four days post inoculation. An increase in the 
respiration rate accompanied the rise in temperature-and a 
serous nasal discharge was observed from the second and third 
day following inoculation. Mohanty et al. (55) additionally 
observed coughing, hyperpnea, dyspnea, anorexia and central 
nervous system depression. The serous nasal discharge became 
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mucopurulent and on auscultation there were inspiratory and 
expiratory rales. Mohanty et al. (55) and Betts et al. (5) 
observed that the animals were not obviously ill and the in-
fection might not be detected clinically. 
Ide and Darbyshire (32) found no macroscopic lesions of 
nasal mucosa, tracheal mucosa, tonsils or bronchial and medi-
astinal lymph nodes. Betts et al. (5) observed small (less 
than 2 cm) , dark red areas of collapse in the lungs. Mohanty 
et al. (55) observed macroscopic lesions typical of respira-
tory illness. The diaphragmatic and cardiac lobes of the 
lungs had areas of consolidation. Additionally, the turbi-
nates and tracheal mucosa were congested. 
Betts et al. (5), on histological examination, saw focal 
necrosis of turbinate epithelium. Adjacent cells were swollen 
and became non-ciliated. Ide and Darbyshire (32) found the 
normal pseudostratified columnar, ciliated cells replaced by 
low cuboidal, non-ciliated cells and cells characteristic of 
focal squamous metaplasia. Affected cells (5) demonstrated 
cytoplasmic vacuolation and degenerative changes of the nucle-
us. Serous glands showed degenerative changes characterized 
by pycnotic nuclei, perinuclear clearing of the cytoplasm and 
excessive granularity of the cytoplasm. Leukocytes were ob-
served in the epithelial layer (5) and sub-epithelial connec-
tive tissue (32). 
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Betts et al. (5) reported necrotic foci involving only 
three to four epithelial cells in the trachea. 
Mohanty et al. (55) found histological changes indicating 
pneumonia of varying severity. Betts et al. (5) found small 
areas of lobular collapse, microatelectasis and interstitial 
pneumonia in gnotobiotic calves. 
Mohanty et al. (55) described alveoli filled with eosino-
philic exudate and containing cellular debris. The alveolar 
walls were thickened by mononuclear infiltration. Large peri-
bronchial lymphoid aggregates and masses of monocytes were 
found in areas with active proliferation manifested by pseudo-
epithelialization. There was a complete loss of alveolar 
structure. Edema and hemorrhage was observed in some alveoli. 
Large areas of atelectasis and emphysema were also observed. 
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III. METHODS AND MATERIALS 
A. Source of Agents 
1. Bovine rhinoviruses 
The bovine rhinovirus FSl-43 used in this study was ·iso-
lated via nasal swabs from one of six animals in a herd exhib-
iting signs of bovine respiratory disease. 
The bovine rhinovirus VC96 was provided by Dr. B. D. 
Rosenquist, University of Missouri, Columbia, Missouri. 
The bovine rhinovirus C-07 was provided by Drs. S. B. 
Mohanty and M. G. Lillie, University of Maryland, College 
Park, Maryland. 
2. Bovine mycoplasma 
Mycoplasma agalactiae var bovis (MAB) strains were pro-
vided by Dr. M. L. Frey, Veterinary Medical Research Insti-
tute, Iowa .. State University, Ames, Iowa. 
B. Cell Culture Methods and Materials 
1. Cell and organ culture materials 
Various bovine cell types were utilized during this study 
to determine their ability to support the replication of bo-
vine rhinovirus. Low passage bovine synovial, aorta, lung and 
tracheal cells obtained from a newborn calf; primary testicle 
cells obtained from a local slaughter house; low passage (31+) 
and high passage (101+) Madin Darby bovine kidney cells 
(MDBK) ; bovine embryonic kidney cell line (GBK) (71) ; bovine 
/ 
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turbinate cells (EBTu); and an epithelial cell which was iso-
lated in pure culture from the fibroblastic EBtu's. 
Bovine tracheal explants obtained from a newborn calf 
were utilized. 
2. Cell culture methods 
All cell culture procedures were conducted under a posi-
tive pressure plexiglass hood. 
Cell cultures utilized in this study were routinely grown 
and maintained in Dulbecco's modification of Eagle's minimum 
essential medium (MEM) in 250 ml plastic cell, culture flasks. 
The growth medium was supplemented with 10% heat inactivated 
(56 C for one hour) fetal calf serum (FCS) and the maintenance 
medium was supplemented with 2% FCS. The medium was buffered 
with 0.075% sodium bicarbonate and a mixture of organic 
buffers: N,N'-bis(2-hydroxethyl)2-aminoethanesulfonic acid 
(BES), N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid 
(HEPES) and N-2-hydroxyethylpiperazinepropane sulfonic acid 
(HEPPS) in final concentrations of 10, 15 and 10 mM, respec-
tively (14). Cultures were incubated routinely at 37 C in 5% 
co 2 atmosphere. Occasionally cells were incubated without in-
creased co2 in a medium consisting of MEM buffered with N~tris 
(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES) in 
sealed containers. 
Cells were subcultured as needed for viral work or at 
intervals to maintain ,cell viability. To subculture cells, 
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they were first washed three times with 2.5 ml Rinaldini.en-
zyme solution (R-saline) , a calcium- and magnesium-free 
Tyrodes-like solution (67). The cell surface was flooded with 
2 ml RTV (R-saline, 0.1% trypsin and 0.02% versene) until the 
cells were rounded-up. The RTV was removed and the flask was 
incubated at 37 c. After apout two minutes the monolayer was 
dispersed with a firm rap of the flask on the table top. The 
cells were suspended in the desired quantity of medium and 
dispensed to recipient containers. 
Routinely cells were dispensed into plastic tissue cul-
ture tubes placed in a horizontal position in stationary racks 
for incubation. On occasions tubes were placed into roller 
drums for incubation. 
Antibiotics were not utilized unless isolation attempts 
were beirtg made from nasal swabs. Crystalline penicillin G 
(100 IU/ml) , dihydrostreptomycin (100 µg/ml) and amphotericin 
B (12. 5 µg/ml) were utilized for control of contamination, but 
were omitted in subcultures. 
Whenever it was feasible an attempt was made to inoculate 
cells with virus immediately after passage of the cells so 
that the cells were still in suspension (75). For certain 
procedures a monolayer was established prior to inoculation 
with virus. When monolayers were to be infected, the growth 
medium was removed and the cell sheet was washed with R-sa-
line. The appropriate viral dilutions were added and the 
23 
tubes were labelled. After adsorption for one hour at 37 C 
the inoculum was poured off and one ml of maintenance medium 
was added. Cells were examined daily for cytopathic effect 
with an inverted microscope. 
3. Storage of cell stocks 
Stock supplies of cells were maintained in liquid nitro-
gen for storage. ,Cells were prepared for storage by suspend-
ing them in medium containing 20% FCS and 10% dimethyl sul-
foxide (DMSO), by volume, after which they were sealed in 
glass containers. The cells were brought slowly to -70 C and 
then immersed in liquid nitrogen until needed. 
4. Tracheal explant culturing methods 
Tracheal explants were placed in wells of Linbro plates 
on areas that had been scratched to facilitate adherence to 
the plastic. The explant was flooded with MEM containing 20% 
FCS. Inoculation was accomplished by dropping the.inoculum 
directly onto the explant, and then replacing the medium. Ex-
plants were observed daily for ciliary activity with an in-
verted microscope. 
5. Plaque assay and purification 
Plaques were produced using a modification of the method 
of Fiala (l6). Dense monolayers of cells were established in 
chambers of Linbro plates. The cells were washed three t~mes 
with R-saline and viral dilutions were added to the appro'pri-
ate chambers. Sufficient MEM was added to produce a meniscus 
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that would facilitate an even distribution of virus on the 
monolayer. The virus was incubated for a minimum of three 
hours at 37 C to allow adequate adsorption. The fluid was re-
moved and the cell surface was rinsed with R-saline. An over-
lay of 1% agarose mixed with an equal volume of 2X .MEM with 4% 
FCS and antibiotic was applied at a temperature of 43 C. The 
overlay was allowed to solidify and the plates were then in-
cubated at 37 C for 72 hours. The cells were fixed by flood-
ing the overlay with 4% formalin for ten minutes. The agarose 
overlay was picked free and removed. The cells were stained 
by flooding with 1% crystal violet for three minutes. After 
drying the plaques could be observed with a background light 
or with an inverted microscope. 
For plaque purification, isolated microplaques were 
marked while viewing with an inverted microscope. The plaques 
were then picked by plunging a Pasteur pipette into the center 
of the microplaque and applying suction until the agarose plug 
was lifted into the pipette. The material obtained was trans-
ferred to a culture tube. The procedure was repeated three 
times to plaque purify the virus. 
The enhancement of plaque formation was determined for 30 
mM/ml MgC12 (BO), 30 µg/ml DEAE-dextran (17) and 0.5 mg/ml 
protamine sulfate (16). A combination of 30 mM MgC1
2 
and 0.5 
mg/ml protamine sulfate was used to determine its effect on 
plaque formation. 
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6. Mycoplasma cultivation 
M-96 broth (21) supplemented with 15% swine serum (96Sw) 
was utilized for cultivation of the mycoplasmas used in calf 
inoculations, and for reisolation of mycoplasmas from experi-
mentally infected calves. 
C. Characterization of Isolant FSl-43 
l. Determination of nucleic acid ~ 
The nucleic acid type was determined with 5-bromodeoxy-
uridine (BUDR) according to the indirect method described by 
Hamparian et al. (24). Monolayers of GBK cells in tissue cul-
ture tubes were washed with R-saline and dilutions of virus 
were added with one ml MEM containing lo'"'4 BUDR. Parainflu-
enza-3 virus and infectious bovine rhinotracheitis virus, 
respectively, were used as RNA- and DNA-containing virus con-
trols. The nucleic acid type was based on suppression of 
replication of DNA virus by BUDR. 
2. Determination of chloroform sensitivity 
The method of Feldman and Wang (15) was utilized to de-
termine the sensitivity of the viral particle to lipid sol~ 
vents. A mixture o.f • 05 ml analytical reagent grade chloro-
form and one ml of tissue culture fluid containing virus 
(1:20) was shaken for ten minutes at room temperature. The 
mixture was centrifuged for five minutes at 500 rpm. The 
supernatant fluid was titrated for infectivity. Infectious 
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bovine rhinotracheitis and a reference strain bovine entero-
virus, respectively, were used as enveloped and non-enveloped 
virus controls. 
3. Determination of size 
Filtration was conducted through sterile filters of pore 
size 0.22 µm (Mil~ipore) and 0.05 µm (Gelman) using a modifi-
cation of the method of Hsiuing (28) . Ten ml of MEM with 10% 
FCS was first passed through the filter, this was followed by 
ten ml of tissue culture fluid containing virus. The viral 
content of the tissue culture fluid was titrated prior to and 
after filtration. 
For negative staining a flask of infected cells was fro-
zen ahd then agitated as they thawed. The tissue culture 
fluid was centrifuged at 5000 rpm for ten minutes. The cell 
precipitate was resuspended and the supernatant fluid was then 
centrifuged a second time at 35,000 rpm for one hour. Both 
the original precipitate and the final lower dense zone were 
prepared for examination using the method of Brenner and Horne 
(10). Twenty drops of distilled water, four drops of 4% phos-
photunstic acid (PTA), one drop 0.1% bovine serum albumin 
(Cohn's fraction IV) and one drop of virus suspension were 
mixed in a depression dish. The mixture was applied to a car-
bon co?ted, collodian filmed 200 mesh grid with an all glass 
Vaponefrin type nebulizer. The grid was examined with a 
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Philips EM 200 electron microscope. The size was determined 
from the negative using a calibrated hand ocular. 
4. Acid lability determination 
Tissue culture fluid containing virus was diluted 1:10 in 
MEM and adjusted to pH 3. 0 according to the method. of Ketler 
et al. (42). The mixture was.incubated at room temperature 
for 30 minutes after which the residual virus content was de-
termined by titration. A reference strain bovine enterovirus 
was utilized as a control. 
5. Thermostability 
The method of Wallis and Melnick (80) was utilized to de-
termine any stabilization by 1 M magnesium chloride. A mix-
ture of 2 M magnesium chloride (MgC1
2
•6H
2
0) was prepared in 
MEM to a final pH of 7.2. The virus was mixed with equal 
volumes of 2 M magnesium chloride or with equal volumes of MEM 
as a control. Portions of th~ mixture were incubated at 50 
and 56 C. At various intervals samples were cooled rapidly 
and titrated for infectivity. 
Samples of virus stored at -70 C were periodically ti-
trated for infectivity. The loss of infectivity of the virus 
in storage was determined. 
6. Characterization of cytopathic effect of cell preparations 
Monolayers of cells were established on microscope slides 
or coverslips for detailed examination of cellular pathology. 
Uninfected control cells and infected cells demonstrating 
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progressive stages of cytopathic change were stained with 
hematoxylin and eosin and May-Gr11nwald-Giemsa. Infected and 
uninfected preparations were examined with acridine orange 
stain (48). Unstained preparations were also examined. 
Monolayers of cells were washed with R-saline and sus-
pended with Rl'V at various intervals following infection. The 
cells were fixed with 2.5% glutaraldehyde (pH 7.4) for 25 min-
utes, washed twice with sodium cacodylate buffer (pH 7.4) and 
post-fixed with 1% osmium tetroxide for 30 minutes. The cells 
were then washed twice in sodium cacodylate buffer, dehydrated 
in ethyl alcohol and embedded in a Epoxy-resin mixture (45). 
Sections were made and stained with uranyl acetate and lead 
citrate (40). Sections were examined in a Hitachi HU-8 
electron microscope. 
D. Serological Test Procedures 
1, .·Hemagglutination 
Hemagglutination of bovine rhinovirus was performed ac-
cording to the procedure reported by Stott and Killington 
(72). Erythrocytes were washed three times in the test buffer 
and resuspended to a concentration of 0.5% in a solution con-
sisting of 50% glucose solution ( 4. 5%) , 50%. veronal buffer 
(complement fixation-test buffer), and 0.05% gelatin. The 
final pH was adjusted to pH 5.0 with 0.2 M NaOAc-HOAc buffer, 
pH 6.0 with 0.05 M phosphate buffered saline, pH 7.0 with 0.05 
M tris buffer or pH 8.0 with 0.05 M tris buffer. Erythrocytes 
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from human group-0, chicken, goose, rat, guinea pig, rabbit, 
bovine, sheep and equine were utilized after collecting one 
volume of blood in an equal volume of Alsever's solution. The 
virus was grown in GBK cells and centrifuged at 2000 rpm for 
five minutes to remove cell debris. The resultant supernatant 
fluid served as the hemagglutinin. Equal volumes of erythro-
cytes in suspension at the various pH's and hemaglutinin were 
mixed in micro-titer plates. The mixtures were incubated at 
4 C, room temperature and 37 c. 
2. complement fixation test 
Complement fixation was performed using the adaptation to 
micro-technique (79). A block titration with 0.25 ml of 
serial doubling dilutions of known positive serum and 0 .• 25 ml 
of serial doubling dilutions of antigen were made in a micro-
ti ter plate. Five C 1 H
50 
units of complement in 0.25 ml volume 
was added and the plates were incubated at 4 C overnight. A 
volume of 0.25 ml of sheep erythrocytes (2.8% standardized 
cell suspension) sensitized to a standardized hemolysin sol·u-
tion was added. The mixture was incubated at 37 C for 30 min-
utes. Results were read after placing the micro-titer plate· 
on a test reading mirror. Antigen, antisera and 2.5 C 1 H
50 
controls were also prepared. 
3. Serum neutralization test 
A serum neutralization test in micro-titer plates accord~ 
ing to the method of Gwaltney (22) and Kriel et al. (43) was 
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utilized. Serial doubling dilutions of serum (0.05 ml) ·were 
made in micro-titer plates. Twenty-five TCID50 of virus (13) 
in 0.05 ml of MEM was added and mixed on a platform shaker. 
The plates were incubated for two hours at 37 C. Cells sus-
pended in 0.05 ml MEM containing 10% FCS were added and the 
plates were incubated at 37 c. The plates were examined.at 
two days for cytopathic effect with an inverted microscope-. 
The serum titer (microplaque reduction titer) was expressed as 
the reciprocal of that dilution with two microplaques or less 
cytopathic change in the cell sheet (13). 
4. Plaque reduction neutralization test 
Serial two-fold dilutions of heat inactivated serum were 
mixed with equal volumes of virus suspension containing ap-
proximately 80 p.f .u. per 0.1 ml. After incubation for two 
hours at room temperature 0.1 ml was inoculated into paired 
wells in a Linbro plate containing a monolayer of GBK cells. 
Equal volumes of virus and diluent were inoculated as a con-
trol. All cultures were overlaid with agarose and incubated 
as described under plaque assay and purification. The serum 
titer was expressed as that dilution which effected a 50% re-
duction in plaque count. 
5. Fluorescent antibody test 
a. Hyperimmune serum production Rabbits were hyper-
immunized with two ml virus suspension in MEM (chloroform 
treated) mixed with an equal volume of Freund' s complete -' 
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adjuvant. The inoculum was injected in equal volumes at five 
sites, one intramuscular, two subcutaneous and two in the foot 
pads. One ml of virus suspension in MEM (chloroform treated) 
was injected into the lateral ear vein on days 21, 28, 29, 32, 
33, 34 and 40. Serum was collected on day 47. 
Chickens were hyperimmunized by inoculation of one ml 
virus suspension (chloroform treated) intravenously at six 
weekly intervals. Serum was collected at the end of seven 
weeks. 
b. Preparation of conjugated antibody The gamma glob-
ulins in ten ml hyperimmune serum were precipitated with 6.1 
ml saturated ammonium sulfate at 4 c. The precipitated glob-
ulin was washed two. or three times with saturated ammonium 
sulfate. The precipitate was redissolved in a minimum volume 
of distilled water and·-~falyzed at 4 C against. at least two 
changes of 0.9% NaCl - 0.05 M sodium carbonate (pH 9.0) for 
24 to 36 hours. The protein content of the globulin was ad-
justed to 20 mg per ml. Conjugation of fluorescein isothio-
cyanate (FITC) with globulin was done by a modification of the 
method described by Marshall et al. ( 4 6) • A solution of 
serum, 18 mg FITC per gram of protein and 1 M sodium carbonate 
(pH 9.0) in a volume of three ml per 18 mg FITC was incubated 
at 25 C for 90 minutes. The globulin-FITC solution was neu-
tralized with 1 M NaH 2Po 4 and then dialyzed overnight against 
0.01 M sodium phosphate buffer (pH 7.5) with three grams of. 50 
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mesh Dowex added to pick up excess FITC. The conjugate was · 
absorbed on a column of DEAE-cellulose, type 40 which was 
equilibrated with O. 01 M NaH2Po 4 .(pH 7. 5). The column was 
washed with 0.01 M NaH 2Po4-0.05 M NaCl (pH 7.5) to elute any 
low-labeled material. The desired globulin was eluted with 
0.01 M NaH2Po 4-0.4 M NaCl (pH 7.5). 
c. Test procedure The direct method of fluorescent 
antibody technique as described by Coons and Kaplan (12) was 
.used. Coverslips with a monolayer of infected and uninfected 
GBK cells were rinsed with fluorescent antibody buffer, fixed 
in cold acetone for 15 minutes and overlaid with labeled glob~ 
ulin for 30 minutes in a moist chamber at 37 c. The cover-
slips were rinsed in fluorescent antibody buffer and distilled 
water for ten minutes each. The coverslips were mounted in 
buffered glycerine. The slides were examined under a flue-
rescertt micro~cope. 
E. Serological Examinations 
l. Serological survey 
Acute and convalescent sera from animals clinically ill 
with symptoms of bovine respiratory disease were tested using 
the serum neutralization test described above. A seroconver-
sion, indicative of recent infection with bovine rhinovirus 
strain FSl-43 was considered to be at least a two-fold in-
' 
crease in microplaque reduction titer. 
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2. Specificity of antibody for the virion 
One ml of bovine serum containing antibody specific for 
bovine rhinovirus (strain FSl-43) was incubated overnight at 
room temperature with 0.1 ml of final viral preparation used 
in negative staining as described above. The mixture was 
centrifuged for one hour at 35,000 rpm. The dense lower zone 
was negatively stained and examined for antibody coated 
virions with a Philips EM 200 electron microscope as described 
above. 
F. Animal Infectivity Studies 
A yearling steer from a university-owned beef herd was 
examined for a serological titer and obtained for experimen-
tation. 
Calves from a university-owned beef herd and from two 
local dairy herds were obtained at birth and placed in indi-
vidual stalls, isolated from other animals and personnel that 
had contact with other cattle. Serum (50 ml) from the first 
surviving calf was fed, within six hours of birth, to each 
s.ubsequent calf as a source of protective antibodies. One ml 
of a solution containing 500,000 I.U. vitamin A, 75,000 I.U. 
vitamin o 2 and 50 I.U. vitamin E was administered intramuscu-
larly. Three ml of a combination of procaine penicillin 
(200,000 I.U./ml) and dihydros'l;reptomycin sulfate (0.25 gm/ml) 
I 
was administered twice daily for the first seven days. Pow-
dered milk cultured with Lactobacillus acidophilus was fed for 
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the first three days and then replaced with a commercial milk 
replacer. The calves were weaned at one month of age and fed 
a commercial calf starter and alfalfa hay. 
Calves were examined for a serological titer against bo-
vine rhinovirus, and mycoplasma isolation was attempted using 
nasal swabs plated on 96Sw medium prior to experimentation. 
1. Group ~ 
A yearling steer (400) was inoculated with bovine rhino-
virus strain FSl-43 for the purpose of passaging the virus ih 
an animal to bolster the animal virulence of the virus, to de-
velop isolation techniques and to serve as a preliminary· in-
vestigation to determine the development of symptoms and 
pathological changes. The animal was inoculated with three ml 
of virus suspension intratracheally and intranasally with one 
ml of virus suspension. The virus suspension had a titer of 
10 4 • 0 TCID50/ml. The steer was examined daily for clinical 
signs, respiration rate and rectal temperature. 
Nasal swabs were collected daily, placed in two ml MEM 
with antibiotics for transport and centrifuged for five min-
utes at 2000 rpm. An inoculum of 0.1 ml was placed into tis-
sue tubes with GBK cells suspended in 0.9 ml of MEM with anti-
biotics. Four tubes were incubated at 37 C in a stationary 
position, four at 34 C in a stationary position and four at 
34 C in a rotor. ' ' Two tracheal explants were inoculated with 
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O.l ml. A series of three passages were made before a sample 
was considered negative. 
Serum was collected before inoculation and at 16 days 
post inoculation. The serum titer was determined utilizing 
the serum neutralization test. 
At 30 days post inocula~ion the steer was slaught~red at 
the university meat lab and a post mortem examination was con-
ducted for the detection of gross pathological lesions. 
2. Group two 
Two calves (410,411) were inoculated intratracheally with 
three ml virus suspension and intranasally with an aerosol of 
one ml virus suspension. The virus suspension contained 
rhinovirus at a titer of 10 4 · 5 TCio50/ml. Calf 409 was placed 
with the first two calves at 24 hours post inoculation as a 
contact control. 
On day six post inoculation, calf 411 was isolated and 
inoculated intratracheally with one ml of supernatant fluid 
from a suspension of pneumonic lung. Organisms resembling 
Mycoplasma agalactiae var bovis, but no viruses, had been 
isolated from the lung suspension. 
The calves were examined daily for respiration rate, 
rectal temperature and other clinical signs. Blood samples 
were collected daily and examined for total white blood cell 
count, differential white blood cell count, hematocrit, plasma 
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fibrinogen, total serum protein and protein ratio (total pro-
tein to plasma f ibrinogen) • 
Nasal swabs were collected daily from day one post inocu-
lation until eight days post inoculation. Swabs were placed 
in one ml MEM with antibiotics for transport, centrifuged at 
2000 rpm for five minutes and 0.1 ml was inoculated into eight 
tubes. Suspended GBK cells were adde.d in 0. 9 ml MEM with 
antibiotics and incubated in a stationary position at 37 C. 
Three serial passages were made before a sample was considered 
negative. 
At the end of the experiment the calves were electrocuted 
and a post mortem examination was conducted: calf 410 (rhino-
virus) on day six post inoculation, calf 409 (contact control) 
five days after initial contact and calf 411 (rhinovirus and 
mycoplasma) six days after mycoplasma inoculation. 
Calves were examined for gross pathological lesions and 
tissues were collected for microscopic examination. 
Swabs were collected from hip, stifle and elbow joint 
fluid; lung; and cervical and mediastinal lymph nodes of calf 
411, and isolation of mycoplasmas was attempted on 96 Sw solid 
medium. Lung tissue was collected from several sites, ground 
in a tissue grinder with M-96 broth, and mycoplasma isolation 
was attempted from 1/10, 1/50 and 1/500 dilutions plated onto 
M-96 solid medium. Serum was collected from calf 411 for the 
serum neutralization test. 
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3. Group three 
Calf 412 was inoculated intranasally and intratracheally 
with four ml rhinovirus (104 TCID50/ml)combined with one ml of 
M-96 medium containing 4 x 10 7 Mycoplasma agalactiae var bovis 
organisms. 
At three days pqst inoculation calf 419 was placed in 
contact with calf '412 for 48 hours. At that time calf 419 was 
inoculated with the above inoculum. Additionally an inoculum 
prepared from fluid collected after administering five ml MEM 
into the nasal cavity of calf. 412 was inoculated intranasally. 
Calf 418 was inoculated intranasally and intratracheally 
with 4 x 10 7 Mycoplasma .agalacti.ae var bovis organisms in four 
ml of M-96 medium. Calf 418 was isolated from all other ani-
mals. 
Calves 421 and 422 were maintained as uninoculated con-
trol calves. They were isolated from all infected calves .. 
Samples were collected and processed as with group two. 
At the termination of th~ experiment the calves were electro-
cuted and a post mortem examination conducted as described 
above. 
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IV. RESULTS 
A. Cell and Organ Culture 
1. Growth studies in bovine cells 
The replication of bovine rhinovirus FSl-43 in selected 
bovine cells is summarized in table 1. High passage MDBK 
Table 1. Replication of bovine rhinovirus FSl-43 in bovine 
cells 
Titer based 
Type of cell on CPEa,b 
Synovial strain 0 
Aortic intima 
strain 0 
Lung strain 1.75 
Tracheal epithe-
lium strain 0 
Testicle strain 0 
MDBK(low passage) 2.0 
(stationary) 
4.5 
(rotated) 
MDBK(high passage) 0 
EB Tu 1. 0 
EBTu-B 3.5 
GBK 4.5 
aAverage of three experiments 
bTiter stated as log
10
Tcro
50
/ml 
Titer based on CPE in GBK 
cells after subculturea,b 
0 
0 
3.5 
0 
0 
4.33 
4.5 
0 
2.67 
5.0 
4.5 
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cells and low passage strains derived from synovia, aortic 
intima, trachea and testicle did not develop CPE, within seven 
days, when inoculated with bovine rhinovirus strain FSl-43. 
GBK cells inoculated with 0.1 ml medium from these cells, 
after freezing and thawing two times, did not develop CPE 
within five days. After passage from each cell type to GBK 
cells without the development of CPE, the cells were deter-
• 
mined to be refractory to bovine rhinovirus infection. 
Lung and EBTu. cells initially exhibited foci of CPE at 
10-l dilutions o:t: virus. After eight serial passages in lung 
cells generalized CPE at lo-1 • 5 dilutions of virus was ob-
tained. CPE In EBTu cells did not progress beyond foci of six 
to eight cells at 10-l dilution of virus after eight serial 
passages. GBK cells inoculated with 0.1 ml of virus suspen-
sion harvested from the eighth serial passages in lung and 
EBTu cells developed CPE indicating titers of 103.• 5 and102 • 67 
TCID50/ml, respectively. 
Low passage MDBK, GBK and EBTu-B cells were found to sup-
port the replication of bovine rhinovirus strain FSl-43. Low 
passage MDBK cells at 24 hours had a CPE characterized by foci 
of rounded, translucent cells. At 48 hours culture tubes had 
a greatly incre~sed amount of cellular debris in the medium, 
but no apparent CPE. Rotation of culture tubes prevented re-
growth of the cell sheet and .facilitated progression of recog-
nizab.le CPE. 
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A comparison of replicate titrations in low passage MDBK, 
GBK and EBTu-B cells is summarized in table 2. To compare the 
Table 2. A comparison of replicate titrations in selected 
cell types 
Type of bo- Titer based Subculture 
vine cell a on CPEb GBK 
MDBK 5.0 5.0 
GBK 5.0 
EBTu-B 4.5 5.0 
aAverage of two experiments 
bTiter stated as log
10
TCID
50
/ml 
titer based on CPEb 
MDBK EBTu-B 
ND 
5.0 ND 
4.0 
relative ability of each cell type to support the replication 
of bovine rhirtovirus, virus harvested from each cell type was 
titrated in GBK and MDBK cells. Titrations were not attempted 
in EBTu-B cells because of the inconsistent exhibition of CPE. 
All cell types were consistently negative for Mycoplasma 
~ on periodic culture attempts on 96Sw solid medium. 
2. Comparison of different incubation conditions 
Virus yield after incubation of replicate titrations of 
infected GBK cells at 33 C in stationary tube.s, at 33 C in 
tubes rotated at one revolution per five minutes and at 37 c 
in stationary tubes were compared. An average of :t;ive experi-
ments revealed very little difference in titers obtained 
(3.54, 3.40 and 3.60 log10TCID50/ml respectively). 
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The time of initial CPE appearance, progression of CPE 
and final virus yield did not prove to be influenced by the 
temperature of incubation of infected cells. Rotation of in-
fected MDBK cell cultures was required to prevent regrowth-of 
the monolayer and the resultant inability to detect foci of 
CPE. The initial appearance of CPE and final virus yield was 
not affected by rotation of cultures or the temperature of in-
cubation. 
CPE was exhibited when EBTu-B cells were infected in a 
suspension of cells that would produce a sparse or incomplete 
monolayer. When a dense monolayer resulted CPE could not be 
detected beyond a 10-l virus dilution. Rotation of cultures 
resulted in a dense monolayer of cells and no visible CPE. 
Temperature and rotation of cultures did not influence the 
time of appearance of CPE and final virus yield. 
All titrations were determined at 72 hours after infec-
tion of cells. Further incubation did not alter the final 
titration based on CPE. Subcultures after 72 hours incubation 
indicated a lower titer of infectious viral particles har-
vested. 
3. Growth studies in bovine tracheal explants 
Ciliary activity of bovine tracheal explants was not af-
fected by bovine rhinovirus isolant FSl-43 in each of three 
attempts. Medium harvested from bovine tracheal explants 
after 24 hours incubation produced CPE in GBK cells. 
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4. Plague production 
Bovine rhinovirus strain FSl-43 utilized in this study 
was successfully plaqued under an agarose overlay after a 
minimum of three hours incubation to allow the adsorption of 
the virus to the cells. 
Seventy-two hours incubation at 37 C was found to be the 
optimum incubation period for plaque production. At that time 
distinct well delineated plaques were evidenced. With addi-
tional incubation time there was no increase in the clarity of 
the. plaques. Even with seven days incubation some plaques did 
not become large enough to be identified as such without 
microscopic examination. After a long incubation time the 
plaques developed an indistinct border and adjacent plaques 
became fused making it difficult to accurately enumerate the 
plaques produced. 
Prior to characterization of the virus and infectivity 
studies the rhinovirus isolant was purified by picking iso-
lated plaques for a series of three procedures. 
Efforts to distinguish and to isolate plaque variants 
were not successful. Microplaques and large plaques selected 
as possible variants produced plaques similar if not identical 
to those characterized as being normal plaques. Serial selec-
tions of apparent variants produced similar results. 
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Incubation at 33 c or 37 C did not affect the time of ap-
pearance of plaques, size of plaques or the final total plaque 
count. 
Plaques could not be visualized with a neutral red over-
lay as utilized in most standard plaque techniques. 
5 •. Enhancement of plaque formation 
Plaques produced by rhinovirus after three to seven days 
incubation can be best described as pinpoint in size (figure 
1). Large isolated plaques reached a maximum of 0.5 mm in 
diameter.. Plaques were clear with an irregular border. 
The addition of 30 µg/ml DEAE.-dextran resulted in a loss 
of viability of the entire monolayer of cells. The monolayer 
was also disrupted when 15 µg/ml DEAE-dextran was added. 
Protamine sulfate in a concentration of 0.5 mg/ml had an 
effect of causing an incomplete destruction of cells within a 
plaque and the.development of an irregular outline giving the 
plaques a fuzzy appearance. 
The addition of a concentration of 30 mM/ml MgC12 re-
sulted in a two- to four-fold increase in plaque diameter 
(final diameter 1 to 2 mm). Plaques (figure 2) were slightly 
irregular in outline but had a distinct border with a complete 
destruction of cells within the plaque resulting in a distinct 
clear plaque. 
Figure 1. Plaques of pinpoint size produced in GBK cells by 
rhinovirus strain FSl-43. Stained with 1% crystal 
violet. Actual size. 
Figure 2. Plaques produced in GBK cells by rhinovirus strain 
FSl-43 after the addition of 30 mM/ ml MgC1 2 to the agarose overlay. Stained with 1% crystal violet. 
Actual size. 
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The addition of a combination of 30 mM/ml MgC1 2 and 0.5 
mg/ml protarnine sulfate produced plaques 0.5 to 2.0 mm in di-
ameter that were fuzzy and with an irregular outline. 
B. Characterization of Isolant FSl-43 
1. Nucleic acid ~ 
The nucleic acid type was indirectly determined to be RNA 
when the addition of 10-4 BUDR, a thyrnidine analog, to the 
medium did not result in a reduction in titer. Parainfluenza-
3 virus (the control RNA virus) was not inhibited by BUDR.but 
infectious bovine rhinotracheitis virus was markedly reduced 
in titer. Table 3 summarizes the results. 
Table 3. Effect of BUDR on virus titer 
Titer of Titer after BUDR 
Virus controla treatmenta 
FS1-43b 3.77 
. c 
Parainfluenza-3 5.75 
Infectious bovine 
rhi~otracheitisd 
7.08 
aTiters stated as log
10
TCID
50
/rnl 
bAverage of five experiments 
cAverage of two experiments 
dAverage of two experiments 
3.77 
5.50 
4.67 
Nucleic 
acid type 
RNA 
RNA 
DNA 
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2. Chloroform sensitivity 
Virus infectivity was not reduced by chloroform treatment 
and in four of five experiments it was increased. The titer 
of a bovine enterovirus reference strain (LCR-4) was not re-
duced but infectivity of infectious bovine rhinotracheitis 
virus could not be detected after exposure to· the same· concen-
tration of chloroform for ten minutes~ The results of chloro-
form sensitivity are summarized in table 4. 
Table 4. Sensitivity to chloroform 
Virus 
FS1-43b 
Bovine entero-
virus LCR-4c 
Infectious bovine 
rhinotracheitisd 
Titer of 
control a 
3.54 
6.33 
8.33 
aTiters stated as log10TCID50
/ml 
bAverage ·Of five experiments 
cAverage of two experiments 
dAverage of two experiments 
3. Determination of size 
Titer after chloro-
form treatmenta 
3.9 
6.0 
<l.0 
The virus passed through 0.22 µm and 0.05 µm filters 
without a reduction in titer. A size of less than 32 nm is 
calculated with the application of Black's factor (6). 
48 
Negative stained viral particles (figure 3) were ca. 26 
to 32 nm in diameter. 
4. Acid sensitivity 
After 30 minutes incubation in a medium of pH 3.0 no re-
sidual viral infectivity could be detected. A reference 
strain bovine enterovirus (LCR-4) similarly treated did not 
exhibit a reduction in titer. The results of acid sensitivity 
are summarized in table 5. 
Table 5. Sensitivity to treatment at pH 3.0 
Virus 
Bovine entero-
virus LCR-4c 
Titer of 
control a 
3.36 
6.0 
aTiters stated as log
10
Tcrn
50
/ml 
bAverage of five experiments 
cAverage of two experiments 
5. Thermostability 
Titer after acid 
treatmenta 
<1. 0 
6.0 
Bovine rhinovirus inactivation curves (figure 4) show 
that 90 percent reduction of infectivity occurred in approxi-
mately 8.0 hours (37 C), 12 hours (34 C), 67 hours (22 c, room 
temperature) and 120 hours (4 C). 
Figure 3. Bovine rhinovirus particle negatively stained with 
phosphotungstic acid. 598,SOOX. 
so 
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Bovine rhinovirus stored at -70 C lost infectivity in a 
linear fashion as demonstrated in figure 5. The time for 90 
percent reduction in infectivity was approximately 50 days as 
determined from the infectivity curve. Four separate stock 
virus preparations lost an average of 92 percent infectivity 
at an average of 78 days storage at -70 C as determine.a by 
titrations for infectivity. 
Rhinovirus was not stabilized against thermoinactivation 
by l M Mgcl 2 ·6H2 o at 50 c. Residual infectivity titers of 
lo1 • 5 and lo1 • O Tcro50/ml were obtained after 15. and 30 min-
utes, respectively, when a sample with an initial infec-
tivity titer of lo 3 • 5 Tcro50 /ml was incubated with l M 
Mgcl2 •H 20 at 5.0 C. The controls incubated without added mag-
nesium were negative for infectivity after 15 minutes 
incubation at 50 c. 
Samples with and without magnesium chloride were negative 
for residual infectivity after 15 minutes incubation at 56 c. 
6. Characterization of cytopathic effect of cell preparations 
In unstained cell preparations the cytopathic effect of 
bovine rhinovirus, figures 6 and 7, was first visualized by 
individual infected cells becoming rounded and shrinking. The 
cells become translucent and appear to be elevated above the 
cell sheet. Adjacent cells become affected and a small clump 
or focus develops. The foci progressively enlarge and coa-
lesce with other foci. As the cells become rounded the 
.. 
Figure 4. Thermoinactivation of strain FSl-43. 
Figure 5. Stability of strain FSl-43 at -70 c. 
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Figure 6. Uninfected GBK cells. Stained with hematoxylin and 
eosin. 430X. 
Figure 7. GBK cells infected with bovine rhinovirus strain 
FSl-43 showing cytopathic change. Stained with 
hematoxylin and eosin. 430X. 
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cytoplasmic processes are retracted. The contracted cells are 
released from the cell sheet leaving a focus with a network of 
strands and _islets of cells. The perimeter of the focus is 
fr.inged with contracting cells. 
Stained preparations revealed a high degree of vacuoliza-· 
tion of infected cells and frequently an eosinophilic granular 
cytoplasmic mass. The nucleus became displaced and pycnotic 
prior to shrinkage o.f the cell. 
Acridine orange stained cells exhibited cytoplasmic areas 
that were more intensely. flame-red than the remainder o·f the 
cytoplasm. These areas appeared to correspond with the eo-
sinophilic masses observed in cells stained with hematoxylin 
and eosin. The nucleus was displaced in the cells exhibiting 
cytoplasmic masses. 
Electron microscopic examination of uninfected cells re-
vealed centrally located nuclei, numerous mitochondria 
throughout the cytoplasm and endoplasmic reticulum. with some 
attached ribosomes. Ribosomes occurred in the cytoplasm, 
either singly or in groups of two or more particles (polyribo-
som_es). 
Infected cells developed clusters of ribosomes which 
formed dense masses. The endoplasmic reticulum became fully 
lined with ribosomes. The cytoplasm became highly vacuolated. 
Initially the vacuoles contained a membrane bound body with a 
cytoplasmic appearance. This body was not in evidence as the 
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vacuoles enlarged and proliferated but was replaced by scat-
tered debris. The vacuolization progressed until the nucleus 
was displaced laterally. The nucleus, in addition to being 
displaced, showed lobulation and shrinkage. 
Virions were not visualized in infected cells grown with 
or without the addition of 30 mM MgC1 2 • 
c. Serological Tests 
l. Hemagglutination test 
Bovine rhinovirus strain FSl-43 did not hemagglutinate 
human group-0, chicken, goose, rat, guinea pig, rabbit, bo-
'vine, sheep and equine erythrocytes at pH 5.0, 6.0, 7.0 or 8.0 
at temperatures of 4 C, 22 C (room temperature) or 37 C. 
2. Complement fixation test 
Complement fixation activity was not detected with bovine 
rhinovirus strain FSl-43 and known positive serum. 
3. Serum neutralization test 
A serum neutralization test in micro-titer plates uti-
lizing 25 TCio50· virus was found to be consistently sensitive 
and reproducible. A microplaque reduction method was uti-
lized, in which two or fewer microplaques (cytopathic foci) 
constituted a positive result. Cytopathic change judged to .be 
larger than a single microplaque, or cytopathic change of 
more than two microplaques was recorded as negative. The 
same end point titer was obtained in 36 replicate doubling 
dilutions of one serum using an estimated 25 TCio
50 
virus from 
58 
three different stock virus reservoirs. The reproducibility 1 
and sensitivity of the test was such that a two-fold increase 
in serum antibody titer was considered to be evidence of a 
seroconversion to the rhinovirus. 
4. Plaque reduction neutralization test 
The plaque reduction neutralization test as utilized in 
this study was not practical for application to large numbers 
of sera. The plaques produced were 2 mm and less in size. 
Microplaques, visible only with a microscopic examination, 
were inevitably present and the slightest defect in the mono-
layer could be confused with a plaque. Thus a microscopic 
examination was necessary for identification and enumeration 
of plaques. 
S. Hyperimmune serum production 
Immune serum was produced in rabbits against strains 
FSl-43 and VC-96. The titers achieved were very low (1/64) .. 
Chickens failed to respond to inoculation with FSl-43 and 
VC-96· and remained without a neutralizing titer. 
6. Serological relationship between FSl-43 and other bovine 
rhinovirus strains 
Utilizing immune serum to rhinovirus strains FSl-43 and 
VC-96 the relationships between virus strains FSl-43, VC-96 
and C-07 were compared. Serum to FSl-43 neutralized the ho-
mologous virus strain to a serum titer of 1/64. It neutral-
ized strains VC-96 and C-07 to a serum titer of 1/16. serum 
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to VC-96 neutralized the homologous virus strain to a serum 
titer of 1/64. It neutralized strains FSl-43 and C-07 to a 
serum titer of 1/16. Thus it is concluded.that bovine rhino-
virus strains FSl-43, C-07 and VC-96 are closely related but 
not identical. 
FITC conjugated antibody to strains FSl-43 and VC-96 
cross-fluoresced with cells infected with virus strains 
FSl-43, VC-96 and C-07. 
7. Fluorescent labeled antibody examination of infected cells 
A perinuclear ring and multiple small isolated cytoplas-
mic foci of specific fluorescence were observed in GBK cells 
infected with bovine rhinovirus, strain FSl-43, after incuba-
tion with a homologous fluorescent labeled antibody. As the 
infected cells became rounded and smaller the cytoplasm became 
intensely fluorescent. 
D. Serology of Bovine Rhinovirus 
1. Serological survey of clinically ill animals 
Serum neutralization testing of acute and convalescent 
sera from 106 animals clinically ill with symptoms of bovine 
respiratory disease revealed that 70.8 percent of animals ex-
amined possessed antibodies to bovine rhinovirus (strain 
FSl-43). Samples examined were from 26 groups of animals rep-
resenting over 5000 animals ranging in age from baby calves to 
mature cattle. The majority of animals were being fed for 
market. 
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A seroconversion, indicating a recent infection with bo-
vine rhinovirus, was detected in 20.8 percent of animals ex-
amined. Table 6 contains serological data for herds and table 
7 contains serological data for individual animals within each 
herd that seroconverted. Animals with a seroconversion to bo-
. vine rhinovirus were found in 15 of the 26 groups examined. 
Serological data obtained by Dr. M. L. Frey (20) from the same 
animals revealed ten of 15 of these groups contained animals 
.that seroconverted to Mycoplasma agalactiae var bovis. Of the 
animals that seroconverted to bovine rhinovirus, 48 percent 
also seroconverted to M. agalactiae var bovis. 
2. Specificity of antibody for the rhinovirus virion 
Electron micrQscope examination of negatively stained 
virions following incubation with an excess quantity of homol-
ogous antibody revealed a specific binding of antibody to 
virions (figure 8). After antibody treatment the virions were 
contrasted in re.lationship to the other cellular debris pres-
ent and thus easier to find and recognize as virions. No 
other cellular debris present in the preparation was bound 
with antibody to the. bovine rhinovirus virion. 
E. Animal Experimentation 
1. Clinical observations 
a. Group one After inoculation with bovine rhinovirus 
strain FSl-43 a yearling steer (400) developed very mild signs 
of a respiratory disease (table 8). The most indicative of a 
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Table 6. Summary of serological test by herd 
Herd No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
No. of ani-
mals tested 
1 
2 
1 
4 
5 
6 
4 
7 
7 
2 
6 
8 
9 
4 
3 
6 
No. with seroconversions to· 
1 
1 
0 
0 
1 
1 
0 
1 
3 
0 
1 
1 
1 
1 
0 
0 
0 
0 
1 
0 
2 
1 
5 
0 
1 
5 
2 
0 
1 
8 
0 
0 
0 
4 
0 
1 
0 
1 
1 
0 
0 
0 
0 
0 
0 
0 
1 
1 
0 
0 
0 
aRV=Rhinovirus FSl-43, microplaque reduction serum neu-
tralization test, seroconversion considered to be a two-fold 
increase in microplaque reduction titer 
bMAB=Mycoplasma agalactiae var bovis, complement fixation 
test, four'-fold and.two-fold increases in titer 
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Table 6. (continued) 
NO. with seroconversions to 
No. of ani-
Herd No. ma ls tested RVa . MAB-4b MAB-2b 
18 6 5 0 l 
19 3 0 0 0 
20 2 0 0 0 
21 3 l 0 l 
22 l l 0 0 
23 4 0 0 0 
24 4 l 0 0 
25 4 0 0 l 
26 4 3 0 0 
Total 111 23 30 8 
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Table 7. Summary of serological tests by individual animal 
Sero conversion to 
Herd No. RVa MAB-4b MAB-2b 
1 + 
2 + 
+ + 
4 + 
+ 
+ 
5 + 
+ + 
6 + 
+ 
+ 
+ 
+ + 
8 + + 
9 + 
+ + 
+ + 
+ + 
+ 
10 + 
+ 
11 + 
aRV=Rhinovirus FSl-43, microplaque reduction serum neu-
tralization test, seroconversion considered to be a two-fold 
increase in microplaque reduction titer 
bMAB=Mycoplasma agalactiae var bovis, complement fixation 
test, four-fold and two-fold increase in titer 
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Table 7. (continued) 
Seroconversion to 
Herd No. RVa MAB-4b MAB-2b 
12 + 
+ 
13 + + 
+ 
+ 
+ 
+ 
ND + 
ND + 
+ 
+ 
14 + - + 
17 - + 
+ 
+ 
ND + 
18 + 
+ 
+ - + 
+ 
+ 
21 + - + 
22 + 
24 + 
25 - - + 
26 + 
+ 
+ 
Figure .8. Bovine rhinovirus coated with a homologous anti-
body. Stained with phosphotungstic acid. 
59 8, so ox. 
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Table 8. Clinical response in calves exposed to rhinovirus 
strain FSl-43 and Mycoplasma agalactiae var bovis 
Calf No. 
Group l 
400 
Group 2 
409 
410 
411 
Group 3 
412 
419 
418 
420 
421 
Inoculum 
NTCFb 
contact control 
RV 
l. RV 
2. Lung sus-
pension 
RV, MABc 
l. Contact 
2. RV, MAB. 
MABC 
None 
None 
Clinical response 
Serous nasal discharge, reddened 
eyes, ocular discharge, increased 
respiration rate, reddened nasal 
mucosa 
Increased respiration rate, in-
creased temperature, reddened 
nasal mucosa 
Reddened nasal mucosa 
Reddened nasal mucosa 
Increased respiration rate, in-
creased temperature, reddened na-
sal mucosa, dyspnea, anorexia 
Serous to mucous nasal discharge, 
reddened nasal mucosa, ocular dis-
charge, cough, increased respira-
tion rate, increased temperature, 
dyspnea and anorexia 
Serous nasal discharge, reddened 
nasal mucosa, increased respira-
tion rate, increased temperature, 
dyspnea, anorexia 
None 
None 
None 
aRV=Rhinovirus strain FSl-43 
bNTCF=Normal (noninfected) tissue culture fluid 
c 
MAB=Mycoplasma agalactiae var bovis 
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respiratory disease was the increase of the respiration rate 
from a pre-inoculation average of 27 respirations per minute 
(figure 9) to a post-inoculation rate of over 40 respirations 
per minute. All other observations were of a mild nature and 
could have been easily overlooked. 
b. Group two Calves 410 and 411 did not exhibit 
clinical signs following intranasal and intratracheal inocula-
tion with bovine rhinovirus strain FSl-43. The only finding 
was a reddening of the nasal mucosa., 
Calf 409 (contact control) showed an increase in respira-
tion rate (figure 9) and an increase in temperature to a high 
of 39.7 c. 
Calf 411 remained asymptomatic for six days following 
intranasal and intratracheal inoculation with bovine rhino-
virus strain FSl-43 except for a reddening of the nasal mucosa 
(see table 8 for clinical observations). After a subsequent 
intranasal and intratracheal inoculation with Mycoplasma ~ 
the temperature increased to a range of 39.4 to 39.7 Con days 
six to ten and the respiration rate increased with a high of 
50 respirations per minute recorded on day nine. Respirations 
became labored and had associated rales. The animal had 
anorexia at the time of the elevations in temperature and 
respiration rate. Calf 411 was obviously ill from a respira-
tory disease. 
Figure 9. Respiration rates of calves 400, 409 and 412 fol-
lowing infection. Calf 400 was inoculated with 
bovine rhinovirus strain FSl-43. Calf 409 was 
placed in contact with calves that were infected 
with bovine rhinovirus strain FSl-43. Calf 412 was 
inoculated with bovine rhinovirus strain FSl-43 and 
Mycoplasrna agalactiae var bovis. 
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c. Group three Calves 412 and 419 became obviously 
ill following intranasal and intratracheal inoculation with 
bovine rhinovirus strain :J;'Sl-43 and Mycoplasma agalactiae var 
bovis. The temperatures (figure 10) increased to a peak on 
day eight of 40.6 and 40.8 C for calf 412 and 419, respective-
ly. There was also an increase in respiration rate to peaks 
of 115 and 81, respectively (figure 9). Both calves were ob-
viously ill and upon the slightest exertion demonstrated 
labored respiration with associated rales. Calf 412 exhibited 
a cough. Both animals showed anorexia from day six post-
inoculation until necropsied. 
Calf 418 after intranasal and intratracheal inoculation 
with Mycoplasma agalactiae var bovis remained asymptomatic 
until necropsied on day eight post-inoculation. All parame-
ters used in this study remained at approximately the same 
levels as the averages of the pre-inoculation recordings. 
Figure 11 compares the temperature response of calf 418 
(mycoplasma infection) with calf 411 (rhinovirus infection). 
Calves 420 and 421 (control animals) did not exceed a 
temperature of 38.6 C or a respiration rate of 28 resoirations 
per minute. 
2. Virus recovery 
Recovery of virus from calves is shown in table 9. Virus 
was not isolated from calves prior to inoculation. The virus 
was isolated from calves 400, 409 (contact control), 411, 412 
Figure 10. Temperature response to bovine rhinovirus strain 
FSl-43 and Mycoplasrna agalactiae var bovis in 
combination. 
Figure 11. Temperature respo nse after inoculation with bovine 
rhinovirus strain FSl-43 (411) and MyCOplasrna 
agalactiae var bovis (418). 
73 
0 412 
41 + 419 
.) u (I) k ::l .µ 
Ill 40 M J'f (I) ~ (I) 
E-1 +---+..._+ of .39 . ·o----. 0 
-3 -2 -1 0 +l +2 +3 +4 +s +6 +7 .+8 +9 +10 
Days after inoculation 
41 + 411 
u 0 418 
(I) 
M 
E 
Ill 40 M 
(I) 
~ 
(I) 
E-1 
-4 -3 -2 -1 0 +l +2 +3 +4 +5 +6 +7 +8 
Days following inoculation 
74 
Table 9. Recovery of bovine rhinovirus from.calves 
Calf no. 
Day of viral recovery 
Inoculurn 2 3 4 5 6 7 8 9 10 0 1 
Group 1 
4.00 
Group 2 
409 
410 
411 
Group 3 
412 
418 
419 
420 
421 
RVa b + 
Contact, 
NTCFa 
+ + 
RV 
1. RV 
2. Lung + 
suspen-
sion 
RV, MABe 
MAB 
RV, MAB 
None 
None 
aRV=Bovine rhinovirus strain FSl-43 
b_ = No viral isolation 
c+ = Viral isolation 
+ + 
+ 
+ + + 
~TCF=Normal (noninfected) tissue culture fluid 
eMAB=Mycoplasma agalactiae var bovis 
+ 
+ 
and 419. Calf 410 was negative for viral isolation on all 
attempts. Calves 418, 420 and 421 were negative for viral 
isolation throughout the study. The virus was readily iso-
lated during the periods that the calves exhibited the most 
\ 
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extreme clinical symptoms. Virus could not be isolated from 
various tissues of calf 419 collected at necropsy. 
3. Mycoplasma isolation 
Mycoplasma ~were not isolated from calves prior to 
experimentation (400 was not tested). Mycoplasma agalactiae 
var bovis was readily isolated from nasal swabs of calves 412, 
418 and 419 following inoculation with reference strain Myco-
plasma agalactiae var bovis. Calf 411 remained negative for 
Mycoplasma ~ following inoculation with pneumonic lung sus-
pension containing organisms resembling !:!:.. agalactiae var 
bovis. !:!:.. agalactiae var. bovis was isolated from the tarsal 
joint fluid of calf 419 at the time of necropsy. 
4. Serological response to bovine rhinovirus strain FSl-43 
The results are summarized in table 10. Animal 400 pos-
sessed a pre-inoculation titer (l/32) to bovine rhinovirus 
strain FSl-43. All other calves had a serum neutralization 
titer of less than 1:4. Calves 400, 411, 412 and 419 had 
seroconverted at the time the experiment was terminated. 
Calves 420, 421 and 418 remained sero-negative to bovine 
rhinovirus FSl-43. Post-inoculation serum neutralization 
tests were not performed on calves 409 and 410 because of the 
short duration of experimentation. 
5. Gross pathological changes observed at necropsy 
The gross pathological changes observed at necropsy are 
summarized in table 11. Calves 409 and 411 had lymph nodes 
/ 
I 
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Table 10. Serological response to bovine rhinovirus FSl-43 
Pre-inocula-
tion titera 
Post-inoculation 
Calf No. Inoculum titerd day 
Group 1 
400 
Group 2 
409 
410 
411 
Group 3 · 
412 
418 
419 
420 
421 
NTCFc,contact 
RV 
1. RV 
2. Lung sus-
pension 
RV,MABd 
MAB 
RV,MAB 
None 
None 
32 
<4 
<4 
<4 
<4 
<4 
<4 
<4 
<4 
128 
ND 
ND 
8 
32 
<4 
16 
<4 
<4 
( 16) . 
(16) 
( 10) 
( 8) 
( 8) 
(15) 
(15) 
aTiter expressed as the reciprocal of the highest serum 
dil7Ition that failed to neutralize 25 TCID50 virus 
bRV=Bovine rhinovirus strain FSl-43 
~TCF=Norrnal (noninfected) tissue culture fluid 
d MAB=Mycoplasma agalactiae var bovis 
that were enlarged and congested. Additionally several one to 
two cm areas of consolidation were observed on all surfaces of 
the lung. Calves 412 and 419 had multiple areas of emphysema 
in the lungs. The dorsal surface of the lungs of calf 419 was 
dusky purple in color. Other calves did not have any apparent 
gross pathological changes. 
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Table 11.. Summary of gross lesions on necropsy 
Calf No. 
Group 1 
400 
Group 2 
409 
410 
411 
Group 
412 
418 
419 
420 
421 
3 
Inoculum 
NTC~,contact 
RV 
1. RV 
2. Lung sus-
pension 
RV MABc , ' 
MAB 
RV,MAB 
None 
None 
Gross lesions 
None 
Lymph nodes congested and en-
larged, 1-2 cm areas of consolida-
tion in lungs 
None 
Lymph nodes congested and.en-
larged, 1-2 cm areas of consolida-
tion in the lungs 
Areas of emphysema in the lungs 
None 
Areas of emphysema in the lungs, 
dusky purple areas on dorsal lung 
surface 
None 
None 
aRV=Bovine rhinovirus strain FSl-43 
bNTCF=Normal (noninfected) tissue culture fluid 
cMAB=Mycoplasma agalactiae var bovis 
6. Hist9pathological findings 
His to logically, nasal mucosa and turbinates from rhino-
virus infected calves, and from calves infected with rhino-
virus and Mycoplasma agalactiae var bovis, were congested and 
had a few areas with micro-hemorrhages. The lamina propria 
had a minimal infiltration of lymphoreticular cells. 
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In calf 412 the serous glands of the nasal mucosa showed 
degenerative changes characterized by blurred cytop~asmic out-
lines and the nuclei were pycnotic with karyorrhexis. There 
was a perinuclear clearing of the cytoplasm. Edema around 
glandular tissue was evident but cellular infiltration was not 
observed. An area of exfoliated debris was found attached to 
a normal appearing epithelium. The trachea also exhibited 
edema of the lamina propria. 
The lungs of all infected calves possessed peribronchial 
lymphoid aggregates. An impingement on bronchioles was ob-. 
served in isolated areas. These areas were not seen in con-
trol calves. 
Calves 409, 410 and 411 had bronchiolar hyperplasia re-
sulting in an apparent occlusion of terminal bronchioles. The 
cells were swollen, had hydropic changes and had basophilic 
staining cytoplasm. 
Lungs of all calves, infected and non-infected, showed. 
focal areas of atelectasis and emphysema. 
The lungs of calves 410, 411 and 419 had interstitial 
edema with some lymphoreticular infiltration. Affected areas 
had an associated congest~on. The alveolar walls in focal 
areas were slightly thickened with mononuclear infiltration. 
The lymph nodes associated with the respiratory tract in 
calves 409 and 411 were congested and had micro-hemorrhages. 
The alveoli of all calves were free of exudate and cellu-
lar debris. 
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V.· DISCUSSION 
A multiplicity of viruses, bacteria, mycoplasmas and 
chlamydia ( 5·3) has been isolated from the nasal passages of 
cattle with respiratory diseases. Rhinoviruses are of current 
interest in relation to the common cold in man. At present, 
there have been few reports on isolations of bovine rhino-
viruses (9,29,54,66,68). This is at least partially explained 
by the fact that rhinoviruses. are extremely difficult to iso-
late and to maintain in culture. This report describes the · 
characterization of a bovine rhinovirus isolated from a clini-
cally ill animal in Iowa. 
The properties described for the isolant FSl-43 fulfill 
current criteria for its designation as a bovine rhinovirus. 
The viral isolant FSl-43 is 26 to 32 nm in diameter, possesses 
RNA, is chloroform resistant and acid sensitive. The virus 
produced a cytopathic effect characteristic of rhinovirus and 
replicated in a narrow range of cells from the bovine. 
Rhinovirus strain FSl-43 was found to be serologically 
related but not identical with strains VC-96 and c-07. 
Mohanty and Lillie (54) found strain C-07 to be related to 
SD-1 and Ide and Darbyshire (34) found that strain FS 3x was 
related to strains C-07, Sd-1 and 181/V. Betts et al. (5) 
found that strain ECll was antigenically distinct from strain 
SD-1. 
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Isolant .FSl-43 was found to replicate in bovine-kidney 
cells (GBK and MDBK) as reported with other isolants (9,30,54, 
68, 83)_. Strain ECll replicated in bovine kidney cells only 
after sev:eral passages in tracheal explants (66). Primary 
calf testicle cells were found refractory to rhinovirus repli-
cation as reported by Bogel and Bohm (9) but at variance to 
results obtained by Ide and Darbyshire (30). 
High passage MDBK cells were found to be refractory to 
viral replication while low passage MDBK cells were found to 
support replication to titers comparable to other -susce~tible 
· cell,s. Reed et al. ( 66) had observed replication in MDBK 
cells at a very low titer. This suggests a difference .in 
cells obtail)ed from di_fferemt sources as observed by Ide and 
Darbyshire (30). Also a difference may exist in the ability 
of different strains to replicate readily in the ce,11 type. 
Replication of bovine rhinovirus strain FSl-43 was ob-
served in fetal lung, EBTu and EBTu-B cells. The presence of 
very limited cytopathic changes within fetal ,lung .and EBTu 
cells is similar to the effect observed in primary thyroid 
cells by Ide and Darbyshire (30). Subcultures in susc_eptible 
cells (GBK) revealed that the rhinovirus was replicating with-
out exhibiting a corresponding degree of CPE. Attempts to 
adapt the virus to these cells were only partially successful. 
No replication of bovine rhinovirus strain FSl-43 was de-
tected in cell strains derived from fetal synovia, aortic 
intima or tracheal epithelium. Although this study has ex-
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tended the number of cell types known to be susceptible to bo-
vine rhinovirus, it is evident that the range is still very 
limited. This is comparable to the H type human rhinovirus. 
Results indicated that in GBK cells there is no disadvan-
tage with a stationary incubation of bovine rhinovirus, as was 
noted by Bogel (8). This is at variance with the reported 
findings of other investigators (30,68). It was necessary to 
rotate infected cultures of MDBK cells in order to obtain CPE 
although total viral yield was unaffected. 
Incubation of cultures at 33 and 37 C did not produce the 
difference in final titer and progression of CPE a~ reported 
by several investigators (9,30,54,68,83). The probable expla-
nation is that the inoculation of cell cultures in sus;pension, 
in this study, resulted in a more rapid adsorption rate, a 
more rapid progression of CPE and a high yield of virus at -a 
earlier time as reported by Thomas, Conant and Hainparian (75). 
By achieving maximal titers and near maximal CPE early, the 
virus is not subjected to the same degree of thermoinactiva-
tion as is the case when monolayers of cells are inoculated.· 
When cells are inoculated while in suspension, CPE is evi-
denced within 12 hours with inocula containing high concentra~ 
tions of virus, and within 48 hours at the endpoint concentra-
tions. This is considerably more rapid than the 18 .. hours to 
two weeks reported by Parsons and Tyrrell (58). 
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Bovine rhinovirus strain FSl-43 was found to replicate in 
bovine tracheal explants but did not affect ciliary activity 
as described (64,65,66). 
Eosinophilic cytoplasmic masses in infected cells stained 
with hematoxylin and eosin corresponded' to flame-red cyto-
plasmic masses in cells stained with acridine orange, as re-
ported by Ide and Darbyshire (30,31). These masses were only 
observed in scattered cells. Fluorescent antibody stained 
cells revealed intracytoplasmic foci of specific fluorescence. 
Elect_ron- micrographs revealed large areas in the cytoplasm of 
infected cells which had vacuoles containing membrane bound 
cytoplasm-like material. Also large accumulations of ribo-
somes were observed. It is probable that the masses observed 
are accumulations of viroplasm. It would be expected that 
virions would be formed in these areas. The presence of 
virions could not be verified in this study even with the ad-
dition of magnesium (7). 
Bovine rhinovirus strain FSl-43 produced plaques under an 
agarose overlay only after a minimum of three hours adsorp-
tion. This is considerably longer than the two hours reported 
by Ide and Darbyshire (34) which conforms with the two hours 
required for adsorption to a monolayer (75). The incubation 
temperature from 22 to 37 C during adsorption did not affect 
the results. Plaques produced by strain FSl-43 were smaller 
than rhinovirus plaques produced by Ide and Darbyshire (34). 
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The addition of 1 M MgC1 2 resulted in a two- to four-fold in-
crease in plaque diameter. 
Bovine rhinovirus strain FSl-43 was thermoinactivated 
after 12 and eight hours at 34 and 37 C, respectively, at a 
rate in agreement with Ide and Darbyshire (31). However, at 
22 and 4 c this isolant was more rapidly inactivated than 
strain RS 3x, as reported by Ide and Darbyshire (31). 
Rosenquist reported a marked variability in the rate of 
thermoinactivation between four rhinovirus isolants. 
The loss of approximately 90 percent of infectivity in 50 
days at -70 C is at extreme variance with RS 3x isolant which 
did not lose infect.ivity titer after one year at -70 C (31). 
Strain FSl-43 was not stabilized against thermoinactiva-
tion at 50 or 57 C with 1 M MgC1 2 as was strain C-07 (54). 
This agrees with findings on strains Sd-1, 181/V and RS 3x 
(31) which were not stabilized. 
Strain FSl-43 did not hemagglutinate erythrocytes under 
the conditions utilized. The complement fixation test did not 
detect known positive serum to bovine rhinovirus strain 
FSl-43. This is probably due to low virus yield as observed 
by Bogel ( 8) . 
Most serology with bovine rhinovirus has been done with 
tube serum neutralization tests. This study also used the 
serum neutralization test but as adapted to a micro test. The 
microplaque reduction serum neutralization test provided the 
84 
advantages of economy of virus, serum, titration plates, 
physical facilities and time. Test results could be obtained 
in 48 hours compared with a minimum of 24 hours to produce a ~ 
dense monolayer of cells and an additional 72 hours to obtain 
test results with the plaque reduction neutralization test. 
Plaques produced in the plaque reduction neutralization 
test were small enough that identification and enumeration re-
quired microscopic examination thus negating the usual advan-
tage of plaque tests. Titers obeained at 50 and 70 percent 
plaque reduction paralleled those obtained by the microplaque 
reduction serum neutralization test but were consistently 
higher by a six- and four-fold factor, respectively. 
The demonstrated reproducibility and sensitivity of the 
microplaque reduction method of serum neutralization was such 
that a two-fold increase in serum titer was considered as a 
seroconversion to bovine rhinoviius. Replicate samples ti-
trated in the plaque reduction neutralization test added cre-
dence to the reliance on a two-fold microplaque reduction 
qualifying as a seroconversion to an infection. 
A somewhat lower percentage of animals demonstrated anti-
bodies to bovine rhinovirus (70.8 percent) than had been 
previously reported. This finding is influenced by the. fact 
that serum samples were primarily from young cattle which Ide 
and Darbyshire (33) found to have lower titers than animals of 
increased age. 
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Ruhnke (69l. found that 90. 6 percent of pneurnonic cattle 
lungs were positive for Mycoplasma ~ Comparison of 
serological data for Mycoplasma ~ (20) with serological 
data for rhinovirus on the same animals found that 48 percent 
of cattle that seroconverted to rhinovirus also seroconverted 
to Mycoplasma agalactiae var bovis. A two-fold increase in 
serum titer was regarded as a seroconversion to !:!.:._ agalactiae 
var bovis because of the slow appearance of antibodies to cer-
tain mycoplasmas in infected cattle (19). 
Several workers have failed to produce signs of respira-
tory disease in calves inoculated with bovine rhinovirus (9, 
32,49,83). Betts et al. (5) and Mohanty et al. (55) demon-
strated clinical signs of respiratory disease but concluded 
that the animals were not obviously ill and a diseased condi-
tion would not be detected under ordinary conditions. The 
present study gave similar results. 
Rosenquist's isolants (68) were obtained from clinically 
ill animals as the only recognized pathogens by either isola-
tion or serology. Rosenquist did not report attempted myco-
plasma isolation or serology. Strain FSl-43 was isolated from 
a clinically ill animal. Mycoplasmas were isolated from the 
same animal as bovine rhinovirus strain FSl-43 (20) . No other 
pathogenic organisms were detected or suspected as a result of 
the isolation and serological procedures utilized. 
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Intranasal and intratracheal inoculation of a calf with 
Mycoplasma agalactiae var bovis did not produce clinical signs 
within eight days. 
Bovine rhinovirus strain FSl-43 and Mycoplasma agalactiae 
var bovis inoculated intranasally and intratracheally into 
calves produced obvious clinical signs characterized by in-
creased temperature (to 40.8 C), increased respiration rate 
(to 115 respirations per minute), slight nasal discharge, red-
dened nasal mucosa, cough, dyspnea and anorexia. 
These findings add support in vivo to the findings by 
Reed (64) that rhinovirus infection provides a more favorable 
environment for growth of mycoplasmas. This was suggested as 
one possible mechanism of the total pathogenic effect of the 
rhinovirus and mycoplasma. 
Macroscopic pathological changes observed at necropsy 
were minor and could readily have been discounted in agreement 
with reported findings (5,32). Mohanty et al. (55) reported 
more serious macroscopic changes in the lungs of infected 
cattle. 
Virus was isolated from nasal swabs of five of six ani-
mals infected with FS!'-43 including a contact control. Virus 
was not isolated from nasal epithelium, turbinates, tonsils or 
lung. similar results were obtained by Bogel and Bohm (9) and 
Mohanty et al. (55) but Betts et al. (5) recovered strain ECll 
from turbinate, tonsil and trachea of infected calves. 
87 
The calves did respond serologically to infection with 
FSl-43. 
All of the histopathological changes observed in experi-
mentally infected calves were minimal and could have been re-
garded as insignificant in routine histological examinations. 
The focal necrosis of turbinate epithelium and changes in 
epithelium from psuedo-stratified columnar ciliated to low 
cuboidal non-ciliated cells as reported by Ide and Darbyshire 
' 
(32) was not observed. Betts et al. (5) observed changes in 
the glands of the turbinates similar to those observed in calf 
412. It is important to note that rhinovirus strain FSl-43 
utilized in this study did not produce cessation of ciliary 
activity in organ cultures of tracheal explants while strains 
RS 3x and ECll utilized by Ide and Darbyshire (32) and Betts 
et al. did cause a cessation of ciliary activity in organ 
culture. 
Marked peribronchiolar lymphoid aggregates and masses of 
monocytes observed by Mohanty et al. (55), as well as other 
changes described, were not comparable to the minor changes 
observed in this study. 
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VI. SUMMARY 
The isolant FSl-43 was characterized as a bovine rhino-
virus. The virus was antigenically related to bovine rhino-
virus strains VC-96, C-07, 181/V, RS 3x and Sd-1. 
Strain FSl-43 was found to replicate in GBK, low passag.e 
MDBK, EBTu, EBTu-B, and fetal lung cells. The virus repli-
cated in tracheal explants but did not stop ciliary action. 
Rotation and temperature (either 33 or 37 C) did not in-
crease the yield of virus or progression of CPE in GBK cells. 
MDBK cells required rotation before CPE was exhibited. EBTu 
and fetal lung cells did not exhibit CPE in correlation with 
the replication of virus. 
Plaques were produced under agarose overlay after three 
hours adsorption. The addition of 30 mM MgC1 2 to the overlay 
enhanced the size of plaques produced by two- to four-fold. 
FSl-43 was more rapidly thermoinactivated at 22, 4 and 
-70 C than strain RS 3x. The virus was not stabilized against 
thermoinactivation by 1 M Mgc1 2 • 
. FSl-43 did not react in hemagglutination and complement 
fixation tests. Comparable results were obtained utilizing a 
microplaque reduction serum neutralization test and the 
plaque reduction neutralization test. 
In a serological survey of Iowa cattle clinically ill 
with BRO, 70.8 percent of the sampled cattle had serum anti-
bodies to bovine rhinovirus. Serological evidence revealed 
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that 20.8 percent of animals examined had been recently in-
fected with bovine rhinovirus FSl-43. Serological evidence 
also revealed that 48 percent of these animals also had been 
recently infected with Mycoplasma agalactiae var bovis. 
After inoculation with bovine rhinovirus strain FSl-43 
calves (three of three) exhibited mild clinical signs of which 
an increased respiration rate was the most noticeable. After 
inoculation with Mycoplasma agalactiae var bovis a calf (one 
of one) did not exhibit clinical signs. After inoculation 
with bovine rhinovirus strain FSl-43 and Mycoplasma agalactiae 
var bovis calves (three of three) exhibited obvious clinical 
signs characterized by incr.eased respiration rate, increased 
temperature, reddened nasal mucosa, dyspnea and anorexia. 
The nasal mucosae and turbinates of infected calves were 
congested grossly a~d histologically. 
Minimal pathological changes were noted. No difference 
was noted between the changes observed in calves monoinfected 
with rhinovirus and those infected with rhinovirus and Myco-
plasma agalactiae var bovis. 
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